Nature 498, 511–515 doi:; DOI: 10.1038/nature12209; published online May 02 2013 Nature 498, 516–520 doi:; DOI: 10.1038/nature12210; published online May 02 2013 Recent reports established transcription of enhancer-derived RNAs (eRNAs), while the evidence for their functional significance remained mostly speculative. Two recent reports published in (Lam et al, 2013; Li et al, 2013) offer the first functional evidence for eRNA transcripts. These analyses further reveal an unexpected level of specificity in the regulation of adjacent mRNAs by eRNAs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730232 | PMC |
| http://dx.doi.org/10.1038/emboj.2013.151 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hammerhead-type FXR agonists induce an enhancer RNA that ameliorates nonalcoholic steatohepatitis in mice.
Elife
April 2024
Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, United States.
The nuclear receptor, farnesoid X receptor (FXR/NR1H4), is increasingly recognized as a promising drug target for metabolic diseases, including nonalcoholic steatohepatitis (NASH). Protein-coding genes regulated by FXR are well known, but whether FXR also acts through regulation of long non-coding RNAs (lncRNAs), which vastly outnumber protein-coding genes, remains unknown. Utilizing RNA-seq and global run-on sequencing (GRO-seq) analyses in mouse liver, we found that FXR activation affects the expression of many RNA transcripts from chromatin regions bearing enhancer features.
View Article and Find Full Text PDFThe dynamic landscape of enhancer-derived RNA during mouse early embryo development.
Cell Rep
April 2024
Westlake Genomics and Bioinformatics Lab, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou 310024, China; School of Life Sciences, Westlake University, Hangzhou 310024, China; Westlake Institute for Advanced Study, Hangzhou 310024, China. Electronic address:
Enhancer-derived RNAs (eRNAs) play critical roles in diverse biological processes by facilitating their target gene expression. However, the abundance and function of eRNAs in early embryos are not clear. Here, we present a comprehensive eRNA atlas by systematically integrating publicly available datasets of mouse early embryos.
View Article and Find Full Text PDFPrognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcoma.
J Transl Med
January 2024
Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China.
Background: Risk stratification and personalized care are crucial in managing osteosarcoma due to its complexity and heterogeneity. However, current prognostic prediction using clinical variables has limited accuracy. Thus, this study aimed to explore potential molecular biomarkers to improve prognostic assessment.
View Article and Find Full Text PDFHammerhead-type FXR agonists induce an eRNA that ameliorates nonalcoholic steatohepatitis in mice.
bioRxiv
February 2024
Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
The nuclear receptor, Farnesoid X Receptor (FXR/NR1H4), is increasingly recognized as a promising drug target for metabolic diseases, including nonalcoholic steatohepatitis (NASH). Protein coding genes regulated by FXR are well known, but whether FXR also acts through regulation of long non-coding RNAs (lncRNAs), which vastly outnumber protein-coding genes, remains unknown. Utilizing RNA-seq and GRO-seq analyses in mouse liver, we found that FXR activation affects the expression of many RNA transcripts from chromatin regions bearing enhancer features.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!